Adverse effect |
Erenumab |
% |
Galcanezumab |
% |
Constipation |
15 |
18,07 |
8 |
14,29 |
Vertigo |
4 |
4,82 |
3 |
5,36 |
Pruritus |
2 |
2,41 |
2 |
3,57 |
Phatigue |
2 |
2,41 |
0 |
0,00 |
Pseudogripal syndrome |
2 |
2,41 |
0 |
0,00 |
Suffocation |
1 |
1,20 |
0 |
0,00 |
Rash |
1 |
1,20 |
0 |
0,00 |
Diarrhea |
1 |
1,20 |
2 |
3,57 |
Urticaria |
1 |
1,20 |
0 |
0,00 |
Sleep disturbances |
1 |
1,20 |
0 |
0,00 |
Paresthesia |
1 |
1,20 |
0 |
0,00 |
Nausea |
0 |
0,00 |
3 |
5,36 |
Injection site reactions |
0 |
0,00 |
1 |
1,79 |
Toxicodermia |
0 |
0,00 |
2 |
3,57 |
|
31 |
37,35 |
21 |
37,50 |